Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Celine Ullrich"'
Autor:
Alessandra Porcu, Miriam Melis, Bernhard Bettler, Rostislav Turecek, Ignazia Mocci, Gian Luigi Gessa, Celine Ullrich, M. Paola Castelli
Publikováno v:
Neuropharmacology 133 (2018): 107–120. doi:10.1016/j.neuropharm.2018.01.024
info:cnr-pdr/source/autori:Porcu A, Melis M, Turecek R, Ullrich C, Mocci I, Bettler B, Gessa GL, Castelli MP./titolo:Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a G?(i%2Fo) protein inhibitor/doi:10.1016%2Fj.neuropharm.2018.01.024/rivista:Neuropharmacology/anno:2018/pagina_da:107/pagina_a:120/intervallo_pagine:107–120/volume:133
info:cnr-pdr/source/autori:Porcu A, Melis M, Turecek R, Ullrich C, Mocci I, Bettler B, Gessa GL, Castelli MP./titolo:Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a G?(i%2Fo) protein inhibitor/doi:10.1016%2Fj.neuropharm.2018.01.024/rivista:Neuropharmacology/anno:2018/pagina_da:107/pagina_a:120/intervallo_pagine:107–120/volume:133
Rimonabant is a potent and selective cannabinoid CB1 receptor antagonist widely used in animal and clinical studies. Besides its antagonistic properties, numerous studies have shown that, at micromolar concentrations rimonabant behaves as an inverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd14ef8453f3c0ffb9727e91fdb52a9a
Autor:
Alessandra, Porcu, Miriam, Melis, Rostislav, Turecek, Celine, Ullrich, Ignazia, Mocci, Bernhard, Bettler, Gian Luigi, Gessa, M Paola, Castelli
Publikováno v:
Neuropharmacology. 133
Rimonabant is a potent and selective cannabinoid CB1 receptor antagonist widely used in animal and clinical studies. Besides its antagonistic properties, numerous studies have shown that, at micromolar concentrations rimonabant behaves as an inverse
Publikováno v:
Molecular and Cellular Neuroscience; Vol 49
Molecular and Cellular Neurosciences
Molecular and Cellular Neurosciences
Inflammation is a hallmark in many neurodegenerative diseases like Alzheimer's disease or vascular dementia. Cholesterol and homocysteine are both vascular risk factors which have been associated with dementia, inflammation and blood-brain barrier dy
Publikováno v:
Journal of Neuroscience Methods
Highlights ► Novel whole brain sagittal organotypic vibrosection in vitro model. ► Survival of cholinergic and dopaminergic neurons. ► Capillaries in whole brain sections in vitro. ► Long nerve fiber growth with neurotracing (Mini-Ruby). ►
Publikováno v:
Neuroscience; Vol 184
Neuroinflammation results in dysregulation of serotonergic neurons in the dorsal raphe nucleus (doR) and is considered to play an important role in the pathophysiology of depression. The aim of the present study was to induce neuroinflammation in a s
Autor:
Christian Humpel, Celine Ullrich
Publikováno v:
Neurochemical Research. 36:1817-1823
Cholinergic neurons are intensively studied, because they degenerate in Alzheimer's disease. Although neurotracer techniques are widely used to study axonal transport, guidance, regeneration or sprouting it is not clear if cholinergic neurons can be
Publikováno v:
European Journal of Neuroscience. 32:1516-1527
Hyperhomocysteinaemia (HHcy) has been identified as a cardiovascular risk factor for neurodegenerative brain diseases. The aim of the present study was to investigate the effects of short (5 months) or long (15 months) HHcy in Sprague–Dawley rats i
Publikováno v:
Current Alzheimer Research. 999:1-7
Alzheimer's disease (AD) is a severe chronic neurodegenerative disease. During aging and neurodegeneration, misfolded proteins accumulate and activate the ubiquitin-proteasome system. The aim of the present study is to explore whether ubiquitin-activ
Publikováno v:
Molecular and Cellular Neurosciences
Alzheimer's disease (AD) is a chronic brain disorder characterized by cognitive impairment, cholinergic dysfunction, inflammation, tau and beta-amyloid pathology and vascular damage. Recent studies have shown, that high cholesterol levels are linked
Publikováno v:
Pharmacology. 86:15-21
In Alzheimer’s disease (AD) neurons expressing the enzyme choline acetyltransferase (ChAT) degenerate and a loss of cholinergic activity directly correlates with cognitive decline. Recent studies have suggested that cholesterol plays a role in AD.